377 related articles for article (PubMed ID: 24134930)
1. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.
Stewart CJ; Alexiadis M; Crook ML; Fuller PJ
Hum Pathol; 2013 Dec; 44(12):2774-81. PubMed ID: 24134930
[TBL] [Abstract][Full Text] [Related]
2. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
[TBL] [Abstract][Full Text] [Related]
3. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
[TBL] [Abstract][Full Text] [Related]
4. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
[TBL] [Abstract][Full Text] [Related]
5. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
[TBL] [Abstract][Full Text] [Related]
6. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
McCluggage WG; McKenna M; McBride HA
Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
[TBL] [Abstract][Full Text] [Related]
7. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
Cathro HP; Stoler MH
Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297
[TBL] [Abstract][Full Text] [Related]
8. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
Oliva E; Garcia-Miralles N; Vu Q; Young RH
Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
[TBL] [Abstract][Full Text] [Related]
9. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
[TBL] [Abstract][Full Text] [Related]
10. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin.
Deavers MT; Malpica A; Liu J; Broaddus R; Silva EG
Mod Pathol; 2003 Jun; 16(6):584-90. PubMed ID: 12808064
[TBL] [Abstract][Full Text] [Related]
11. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract][Full Text] [Related]
12. [Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors].
Zheng XZ; Ma JH; Chen TB; Xu F; Zou ZY; Zhang LH; Jin YL; Zhan Y
Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):794-799. PubMed ID: 32746545
[No Abstract] [Full Text] [Related]
13. FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors.
Chiang S; Staats PN; Senz J; Kommoss F; De Nictolis M; Huntsman DG; Gilks CB; Oliva E
Am J Surg Pathol; 2015 May; 39(5):618-23. PubMed ID: 25581731
[TBL] [Abstract][Full Text] [Related]
14. Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network.
Maillet D; Goulvent T; Rimokh R; Vacher-Lavenu MC; Pautier P; Alexandre J; Pujade-Laurraine E; Devouassoux-Shisheboran M; Treilleux I; Ray-Coquard I; Savina A
Gynecol Oncol; 2014 Jan; 132(1):181-7. PubMed ID: 24157616
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of unclassified sex cord-stromal tumors of the testis with a predominance of spindle cells.
Renshaw AA; Gordon M; Corless CL
Mod Pathol; 1997 Jul; 10(7):693-700. PubMed ID: 9237180
[TBL] [Abstract][Full Text] [Related]
16. Lack of mutation of DICER1 and FOXL2 genes in microcystic stromal tumor of the ovary.
Meurgey A; Descotes F; Mery-Lamarche E; Devouassoux-Shisheboran M
Virchows Arch; 2017 Feb; 470(2):225-229. PubMed ID: 27830327
[TBL] [Abstract][Full Text] [Related]
17. Genetics and genomics of ovarian sex cord-stromal tumors.
Fuller PJ; Leung D; Chu S
Clin Genet; 2017 Feb; 91(2):285-291. PubMed ID: 27813081
[TBL] [Abstract][Full Text] [Related]
18. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
Young RH
Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
[TBL] [Abstract][Full Text] [Related]
19. FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
Wessman S; Fuentes BB; Severin-Karlsson J; Westbom-Fremer S; Nistér M; Kokaraki G; Petta TB; Haglund F; Carlson JW
Int J Gynecol Pathol; 2024 Jan; 43(1):78-89. PubMed ID: 37255476
[TBL] [Abstract][Full Text] [Related]
20. 14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors.
Chen L; Yang B
Int J Gynecol Pathol; 2013 Mar; 32(2):156-62. PubMed ID: 23370648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
